These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35174853)

  • 61. FAK Signaling in Rhabdomyosarcoma.
    Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Update on molecular findings in rhabdomyosarcoma.
    El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
    Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
    Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
    Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction.
    Frascella E; Rosolen A
    Am J Pathol; 1998 Feb; 152(2):577-83. PubMed ID: 9466584
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
    Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical manifestations and diagnosis of rhabdomyosarcoma of childhood at different sites].
    Sharov TA
    Vestn Ross Akad Med Nauk; 2000; (7):16-9. PubMed ID: 10961142
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
    Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
    BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen.
    Greenberg JA; Somme S; Russnes HE; Durbin AD; Malkin D
    Cancer Res; 2008 May; 68(9):3476-85. PubMed ID: 18451176
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
    Alderman MA; Thomas DG; Roh MH
    Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
    Hajdin K; D'Alessandro V; Niggli FK; Schäfer BW; Bernasconi M
    PLoS One; 2010 May; 5(5):e10445. PubMed ID: 20454619
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The natural origins of cytostatic compounds used in rhabdomyosarcoma therapy.
    Lewandowski D; Szewczyk A; Radzka J; Dubińska-Magiera M; Kazimierczak W; Daczewska M; Migocka-Patrzałek M
    Adv Clin Exp Med; 2023 Oct; 32(10):1179-1191. PubMed ID: 36920267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
    Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z
    J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.
    Pal A; Chiu HY; Taneja R
    Redox Biol; 2019 Jul; 25():101124. PubMed ID: 30709791
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Histology and fusion status in rhabdomyosarcoma.
    Rudzinski ER
    Am Soc Clin Oncol Educ Book; 2013; ():425-8. PubMed ID: 23714565
    [TBL] [Abstract][Full Text] [Related]  

  • 80. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
    Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
    Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.